Login
Login     |     Register     |     Recover Username/Password

General Investing

Google Inc (GOOG) Offers Advertisers Best Understanding of Return on Investments

May 15, 2013

Google Inc (GOOG) continues to gain market share as the company surpasses its competitors by providing advertisers with a more solid understanding of the return on investments of their advertising dollars, says Brian Pitz, Managing Director and Senior Research Analyst at Jefferies & Company, Inc.

“The data is overwhelming in terms of the share [Google] continues to gain. But the view is, these guys are really well-positioned to evolve their products, whether it’s search, video, display or mobile. We think it is the best-of-breed offering that provides advertisers with a solid understanding of their ROIs, return on investments, on advertising spending,” Pitz said.

FOR MORE INFORMATION ABOUT THIS INTERVIEW CLICK HERE.

Pitz discusses the difficulty of understanding metrics on mobile and display, highlighting certain display ad formats that may influence consumer behaviors down the road, yet GOOG is the frontrunner on the measurement side in providing advertisers with more information.

“How do you attribute sales for an ad format which might influence to make a purchase several weeks down the road versus an ad format which receives last click attribution? The fact is, some display ad formats may actually have much more influence on consumer behaviors that is not really being captured or understood, so when you calculate the ROI, it is very complicated to determine the true ROI,” Pitz said. “We think Google is doing a better job than anyone else on the measurement side and believe that it is easier for advertisers to spend more money there.”


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now